Year: 2016
Type: article
Abstract: Understanding the molecular mechanisms that precede and give rise to a migraine attack is key to developing new therapeutic strategies.Advances towards this goal have recently been made through genome-wide association studies, which have identified new genetic components of migraine that highlight vascular etiologies and underline the polygenic nature of this disorder.
Source: Genome Medicine
Institutions: Broad Institute, Harvard University, Massachusetts General Hospital, Stanley Center for Psychiatric Research, Oslo University Hospital, University of Oslo, Queensland University of Technology, Helsinki University Hospital, Brigham and Women's Hospital, University of Helsinki, Institute for Molecular Medicine Finland
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,290
Funders: Brigham and Women's Hospital, Massachusetts General Hospital, Helsingin Yliopisto, Helsingin ja Uudenmaan Sairaanhoitopiiri, Broad Institute, Queensland University of Technology, Universitetet i Oslo, Stanley Center for Psychiatric Research, Broad Institute, National Institute of Neurological Disorders and Stroke
OpenAlex ID: W2509087331